About this trial

The aim is to assess early right ventricular systolic dysfunction in psoriatic arthritis patients using RV strain echocardiography

Eligibility criteria

Qualifiers

Psoriatic arthritis patients according to CASPAR criteria

Psoriatic arthritis patients without overt cardiovascular symptoms

Patients with age between 20 to 50 years of age

Disqualifiers

Other systemic autoimmune diseases

Patients with a history of known valvular disease, atrial fibrillation or any other arrhythmia , heart failure, ischemic cardiomyopathy severe obstructive pulmonary diseases and metabolic syndrome.

Patients with medical disorders as renal, congenital heart diseases, hematological disorders and cancer patients.

Patients taking certain drugs that have been confirmed to be risk factors for PAH such as appetite suppressant intake drugs (aminorex, fenfluramine derivatives and benfluorex) and chemotherapeutic agents.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

60 Participants
are grouped into 2 trial groups

Locations

1
Ain Shams University00202, CairoAbbassia, Egypt

Sponsors and collaborators

Ain Shams University

Lead sponsor